ViennaLab Diagnostics GmbH

Viennalab Diagnostics GmbH is a company that specializes in the development and distribution of in vitro diagnostic assays for the detection of genetic variants associated with various conditions, including genetic disorders, cancer, and pharmacogenetics. The company offers a range of products, including RealFast Assays, StripAssays, and NGS Assays, which are designed to provide easy-to-use and customized solutions for genetic testing. Viennalab's products are CE/IVD labeled and comply with international quality standards, such as EN ISO 13485 and IVDR 2017/746 (EU). The company has an international network of distribution partners and operates globally, providing its products and services to customers in over 100 countries.

ViennaLab - Established Innovations in Diagnostics

ViennaLab, founded 1990, develops and manufactures products for medical in-vitro diagnostics in the fields of genetic diseases and predispositions, pharmacogenetics, and oncology.

ViennaLab focus on cardiovascular diseases and inherited disorders of iron metabolism (haemochromatosis). The range of products also includes diagnostic kits for Thalassemia, Familial Mediterranean Fever (FMF), Gaucher Disease, Alzheimer, HLA-B27, and Sugar & Lactose Intolerance. New kits are launched every year. The recent CAH StripAssay for neonatal screening helps earlier results to confirm CAH.

In the Pharmacogenetics line ViennaLab offers kits for better therapies with coumarin (PGX-Thrombo), tiopurines (PGX-TPMT), HAART (PGX-HIV), flourouracil (PGX-5FU), KRAS & BRAF.

The technology of ViennaLab's StripAssays is based on reverse-hybridization and PCR amplification.

It involves three steps: DNA isolation, specific gene sequences are amplified and biotin-labelled in a single multiplex amplification reaction and the amplified products are selectively hybridized to a test strip, which contains oligonucleotide probes immobilized as parallel lines. Bound biotinylated sequences are detected using streptavidin-alkaline phosphatase and color substrates. Results are visible to naked eye.

A software scans the results and helps generating reports and storing patients' data.

ViennaLab aims at marketing its products internationally in close collaboration with highly committed distributing partners.

Cancer
Genetic Disorders
Genetic Predispositions
Pharmacogenetics